Alex Sirois

Alex Sirois

Alex is a freelance contributor to Ïã¸ÛÁùºÏ²ÊÐþ»ú who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for Ïã¸ÛÁùºÏ²ÊÐþ»ú is to bring value to the reader.

You can follow Alex on

Recent Articles

Bankruptcy Blunders: 3 Stocks to Dump Before They Go Bust

Investors would do well to sell these stocks before one or more of them head to zero in the near to mid term.

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

Oil’s Penny Powerhouses: 3 Small-Cap Stocks Gushing with Potential

Small-cap penny oil stocks are rife with potential as production surges and prices remain elevated suggesting ongoing opportunity.

Hidden Treasures: 7 Undervalued Tech Stocks to Dig Up Now

Buying these undervalued tech stocks looks like a strong strategy in May and beyond, as value investing usually pays off.

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.